title: The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism.
abstract: OBJECTIVE
  To describe the use of inhaled aerosolized prostacyclin (IAP) in a patient with life-threatening pulmonary hypertension secondary to pulmonary embolism and to discuss the possible use of inhaled prostacyclin in the management of pulmonary embolism.
  
  
  METHODS
  Case report.
  
  
  METHODS
  Intensive care unit of a university teaching hospital.
  
  
  METHODS
  One patient with severe pulmonary hypertension secondary to acute-on-chronic pulmonary embolism.
  
  
  METHODS
  Conventional medical management of massive pulmonary embolism and inhaled aerosolized prostacyclin (IAP).
  
  
  RESULTS
  Description of clinical course, haemodynamic data and gas exchange data.
  
  
  CONCLUSIONS
  We describe a patient with massive pulmonary embolism for whom the addition of IAP to his therapy appeared to result in a transient improvement in pulmonary haemodynamics and gas exchange.
authors.affiliation: Department of Intensive Care, Sir Charles Gairdner Hospital, Nedlands, Western Australia.
authors.forename: S A
authors.initials: SA
authors.lastname: Webb
authors.forename: S
authors.initials: S
authors.lastname: Stott
authors.forename: P V
authors.initials: PV
authors.lastname: van Heerden
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols; D000368:Aged; D011464:Epoprostenol / Q000627:therapeutic use*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D011655:Pulmonary Embolism / Q000150:complications*; D018497:Ventricular Dysfunction, Right / Q000209:etiology
chemical_list: D000336:Aerosols; D011464:Epoprostenol